logo

For the Inventor, By the Inventor

Nyack, NY, United States of America

Charles V Grudzinskas

This inventor holds 39 USPTO granted patents, primarily in Prostaglandin Chemistry. Top assignees: American Cyanamid Company, American Cyanamid, Other. Active years: 1977-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles V Grudzinskas. Retrieved from https://idiyas.com/inventor/charles-v-grudzinskas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 39

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 112(Granted Patents)


Location History:

  • Garnerville, NY (US) (1977 - 1985)
  • Nyack, NY (US) (1977 - 1985)
  • Upper Nyack, NY (US) (1983 - 1988)

Company Filing History:

goldMedal36 out of 3,580 
 
American Cyanamid Company
 patents
silverMedal1 out of 33 
 
American Cyanamid
 patents
bronzeMedal1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1977-1988

Loading Chart...
Areas of Expertise:
Prostaglandin
15-Deoxy
Vinylstannyl
Cyclopropyl
Analog Synthesis
Alkenylzirconium
Prostacyclin
Aryloxy Derivatives
Ethynyl Compounds
Tetranorprostanoic
Prostaglandin E Series
Prostaglandin F Series
39 patents (USPTO):Explore Patents
1. 4730065 - 15-deoxy-16-hydroxy-16-substituted prostanoic acids and congeners (1988-03-08),
2. 4535180 - 11-Deoxy-11-substituted prostaglandins of the E and F series (1985-08-13),
3. 4518790 - 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic (1985-05-21),
4. 4504417 - 15-Deoxy-16-hydroxy-16-substituted prostanoic acids and congeners (1985-03-12),
5. 4477388 - Vinylstannyl derivatives (1984-10-16),
6. 4444691 - 11-Cyano-prostaglandins of the F-series (1984-04-24),
7. 4429148 - 15-Deoxy-16-hydroxy-16-substituted prostanoic acids and congeners (1984-01-31),
8. 4415746 - 16-Aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives (1983-11-15),
9. 4415501 - Alkenylzirconium reagents useful for prostaglandin analog synthesis (1983-11-15),
10. T103403 - 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic (1983-09-05),
11. 4390711 - 16-Hydroxy-5-iodo-prostacyclin analogs of the 1 series (1983-06-28),
12. 4387241 - Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives (1983-06-07),
13. 4358605 - 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic (1982-11-09),
14. 4328358 - 15-Deoxy-16-hydroxy-16-substituted prostanoic acids and congeners (1982-05-04),
15. 4281153 - 15-Deoxy-16-hydroxy-16-substituted prostanoic acids and congeners (1981-07-28),

Title: Charles V Grudzinskas: Pioneering Innovations in Medicine

Introduction:

Charles V Grudzinskas, a renowned inventor based in Nyack, NY, is a trailblazer in the field of medicine, with an impressive track record of 39 patents to his name. His relentless pursuit of innovation has led to groundbreaking discoveries that have significantly impacted the healthcare industry.

Latest Patents:

Among his latest patents are the 15-deoxy-16-hydroxy-16-substituted prostanoic acids and congeners, which have shown promise as bronchodilators, hypotensive agents, and in controlling excessive gastric secretion. Additionally, his work on 11-deoxy-11-substituted prostaglandins of the E and F series has opened new avenues in the treatment of hypertension and gastric ulcers.

Career Highlights:

Having worked at American Cyanamid Company and American Cyanamid, Charles V Grudzinskas has honed his expertise in pharmaceutical research and development. His innovative approach to drug discovery has led to the creation of novel therapeutic agents that have the potential to improve the lives of countless individuals.

Collaborations:

Throughout his career, Charles V Grudzinskas has collaborated with esteemed colleagues such as Martin J Weiss and Sow-Mei L Chen. Together, they have contributed to a culture of innovation and excellence, driving forward cutting-edge research in the field of medicine.

Conclusion:

In conclusion, Charles V Grudzinskas stands as a testament to the power of innovation and the profound impact that one individual can have on the world. His pioneering spirit and dedication to advancing medical science continue to inspire future generations of inventors and researchers to push the boundaries of what is possible, shaping the future of healthcare for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…